Drug Side Effects
Search
CONGENITAL PARVOVIRUS B19 INFECTION
CONGENITAL PARVOVIRUS B19 INFECTION
was reported 1 times
CONGENITAL PARVOVIRUS B19 INFECTION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
1
0.0001
1
Calcium [EPC]
1
0.0000
2
Platelet Aggregation Inhibitor [EPC]
1
0.0000
3
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000